Trifexis is a drug owned by ELANCO US INC. It is protected by 3 US drug patents filed from 2013 to 2021. All patents have expired. Details of Trifexis’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US5496931 | 05 Mar, 2013 | Expired |
Exclusivity Information
Trifexis holds 1 exclusivity out of which 1 has expired. Details of Trifexis's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Jan 04, 2014 |
About Trifexis
Trifexis is a drug
owned by ELANCO US INC.
Trifexis uses
Milbemycin Oxime, Spinosad as the active
ingredients.
Active Ingredient:
Trifexis uses
Milbemycin Oxime,
Spinosad
as the active ingredients.
Check out other Drugs and Companies using
Milbemycin Oxime, Spinosad ingredient.